Literature DB >> 12207169

Factors influencing the growth hormone response to growth hormone-releasing hormone in children with idiopathic growth hormone deficiency.

C Groisne1, C Trivin, J C Souberbielle, R Brauner.   

Abstract

OBJECTIVE: To evaluate the factors influencing the growth hormone (GH) response to GH-releasing hormone (GHRH) test in idiopathic GH deficiency.
METHODS: 28 patients aged 4.9 +/- 0.7 years with certain GH deficiency were given GHRH (2 microg/kg).
RESULTS: The GH peak after GHRH was correlated negatively with age at evaluation (r = -0.37, p < 0.05) and body mass index (r = -0.44, p = 0.02), and positively with anterior pituitary height (r = 0.47, p = 0.02), GH peak after non-GHRH stimulation (r = 0.78, p < 0.0001) and spontaneous GH peak (r = 0.82, p = 0.007). It was lower in the patients aged >5 years than in the youngest (p = 0.04), but it was similar in the patients with and without features suggesting a hypothalamic origin.
CONCLUSION: The GH response to GHRH test cannot be used to differentiate between hypothalamic and pituitary forms of idiopathic GH deficiency, probably because the GH response decreases after the first 5 years of life, whatever the origin of the deficiency. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207169     DOI: 10.1159/000064660

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  2 in total

1.  Pituitary stalk interruption syndrome in 53 postpubertal patients: factors influencing the heterogeneity of its presentation.

Authors:  Luu-Ly Pham; Pierre Lemaire; Annie Harroche; Jean-Claude Souberbielle; Raja Brauner
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

2.  Factors influencing the growth hormone peak and plasma insulin-like growth factor I in young adults with pituitary stalk interruption syndrome.

Authors:  Mariana Marcu; Christine Trivin; Jean-Claude Souberbielle; Raja Brauner
Journal:  BMC Endocr Disord       Date:  2008-07-11       Impact factor: 2.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.